LetterCancer

Comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”

See allHide authors and affiliations

Science Translational Medicine  27 Jul 2016:
Vol. 8, Issue 349, pp. 349le1
DOI: 10.1126/scitranslmed.aaf9121

Article Information

vol. 8 no. 349 349le1

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 18, 2016
  • Accepted for publication June 21, 2016
  • .

Author Information

  1. Jérémie Decalf1,
  2. Rosa Barreira da Silva1,
  3. Scott Werneke1 and
  4. Matthew L. Albert1,2,3,*
  1. 1Department of Cancer Immunotherapy, Genentech, South San Francisco, CA 94080, USA.
  2. 2The Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, 75724 Paris, France.
  3. 3INSERM U1223, 75724 Paris, France.
  1. *Corresponding author. Email: albertm7{at}gene.com

Altmetric

Article usage

Article usage: July 2016 to August 2019

AbstractFullPdf
Jul 201613869467
Aug 20169347289
Sep 20161252119
Oct 2016101813
Nov 2016841112
Dec 201683165
Jan 201798911
Feb 2017110819
Mar 2017154710
Apr 20177764
May 201771611
Jun 20173377
Jul 20174664
Aug 201760105
Sep 20176293
Oct 201714788
Nov 2017110120
Dec 20179043
Jan 201897172
Feb 20187551
Mar 201852123
Apr 201846143
May 20184981
Jun 20184853
Jul 20184034
Aug 20184555
Sep 20183293
Oct 20182563
Nov 20182775
Dec 20184661
Jan 20194527
Feb 20193553
Mar 20193472
Apr 20195544
May 20193362
Jun 20191731
Jul 20193789
Aug 20191032